Tower Properties Co. engages in the business of owning, developing, leasing and managing real property. The company is headquartered in Overland Park, Kansas. The Company’s real estate property consists of office buildings, apartment complexes and land held for future sale or development. Its properties include Barkley Place Building, 7911 Forsyth Office Building, 6601 College Boulevard Office Building, Corinth Office Building, Corinth Executive Office Building, Indian Creek Campus I Office Building, Creekview Corporate Center Office Building, Timberlands Office Building, New Mark Subdivision, Hillsborough Apartment Complex, Peppertree Apartment Complex, Harper Square Apartment Complex, Hutton Farms Apartment Complex, Tuckaway Apartment Complex, Briarwood Apartment Complex, Tuckaway at Shawnee Apartment Complex, Hillsborough Apartments and others. The company also provides construction management for commercial and multifamily properties.
TG Therapeutics Inc 주요 수익원은 Novel Treatments for B-cell Diseases이며, 최신 수익 발표에서 수익은 329,004,000입니다. 지역별로는 United States이 TG Therapeutics Inc의 주요 시장이며, 수익은 329,004,000입니다.
Tower Properties Co은 수익성이 있나요?
예, 최신 재무제표에 따르면 TG Therapeutics Inc의 순이익은 $447입니다.